I’m Head of Product and Commercial Operations at Hatcher+, where I oversee the company’s AI initiatives and global sales operations. My work centers on developing and scaling predictive intelligence for early-stage investing through Hatcher Score, our proprietary AI platform. I lead the application of 75+ machine learning models that power 12+ predictive scores and projections, helping forecast company success with measurable accuracy. I’ve launched multiple AI-driven products, including an investment search engine that evaluates 23 dimensions of company performance and content-assessment tools that automate early-stage deal analysis. I also spearhead strategic partnerships, including collaborations with Fortune 10 companies, to expand the commercial reach and practical applications of our AI across the venture ecosystem.
In parallel, I lead the implementation of the operational and analytics systems that power our global sales team. This includes designing the data infrastructure, reporting frameworks, and process automations that enable high-velocity deal flow, forecasting, and performance optimization across our network. My focus is on building scalable systems that align commercial execution with product intelligence, ensuring our teams operate with clarity, precision, and measurable impact.
Within Hatcher, I’ve made six seed-stage investments (True Metrics, Deasy Labs (EXIT), Andromeda Surgical, Kobalt Labs, and Affinity) and am an angel investor in Frontiers Markets.
Previously, I was CEO and Co-founder of Medinas Health, a reverse logistics and data platform that helped healthcare institutions effectively resell and redeploy major capital equipment—saving hospitals millions in sales equivalency and diverting approximately 50,000 pounds of waste from landfills.
I also co-founded mask-match.com, a nonprofit peer-to-peer logistics initiative that matched 821,000 masks from 6,200 donors to 7,300 frontline healthcare providers during the critical first three months of the COVID-19 pandemic.